LANA-specific CD8+ T cells are regularly identified in patients and their concurrent appearance along with clinical improvement of KS patients following reduced immunosuppressive treatment has suggested that high levels of LANA-specific CD8+ T cells responses might confer protection against KS oncogenesis92–95. This evidence concerns the gene CD8A and Kaposi's sarcoma.